연구성과

국내 원료 허가 (Korean DMF) 2018. 03. 31 기준

국내 원료 허가 (Korean DMF)
연도 APIs No
2018년 Raloxifene HCl, Celecoxib, Imidafenacin, Bazedoxifene acetate,
Ceftriaxone Sodium
5
2017년 Oseltamivir, Cilostazol, Oxaliplatin, Clopidogrel Bisulfate, Vildagliptin,
Irbesartan, Pregabalin, Losartan Potassium, Gefitinib, Donepezil HCl H2O,
Ranitidine HCl, Clarithromycin, Pregabalin, Gefitinib
14
2016년 Pitavastatin Ca, Gemcitabine HCl, Sulbactam Na,
Tadalafil, Duloxetine HCl, Simvastatin,
Atomoxetin HCl, Atorvastatin Ca, Cinacalcet HCl,
Palonosetron HCl, Tenofovir disoproxil fumarate
11
2015년 Bortezomib trimer, Silodosin, Solifenacin succinate 3
2014년 Bosentan hydrate, Gefitinib 2
2013년 Atorvastatin Ca hydrate, Sulbactam Na 2
2012년
이전
Adefovir dipivoxil, Amlodipine maleate, Atorvastatin Ca (α form),
Atorvastatin Ca anhydrous (α form), Atorvastatin Ca anhydrous,
Atorvastatin Ca (1 form), Cefaclor, Cefcapene pivoxil HCl hydrate,
Cefmetazole Na, Cefotaxime Na, Cefpodoxime proxetil, Ceftizoxime Na,
Cefuroxime axetil, Cilostazol, Clarithromycin, Clopidogrel bisulfate,
Clopidogrel resinate, Donepezil HCl monohydrate, Gemcitabine HCl,
Gimeracil, Imatinib mesylate, Irbesartan, Lobeglitazone sulfate,
Losartan K, Loxoprofen Na, Olmesartan medoxomil, Oteracil K,
Pemetrexed disodium 2.5 hydrate, Pitavastatin Ca, Pranlukast,
Ranitidine HCl, Simvastatin
32
총합계 69
close
close